Sonali N. Shah

624 total citations
19 papers, 499 citations indexed

About

Sonali N. Shah is a scholar working on Psychiatry and Mental health, Pharmacology and Oncology. According to data from OpenAlex, Sonali N. Shah has authored 19 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 4 papers in Oncology. Recurrent topics in Sonali N. Shah's work include Dementia and Cognitive Impairment Research (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Sonali N. Shah is often cited by papers focused on Dementia and Cognitive Impairment Research (4 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). Sonali N. Shah collaborates with scholars based in United States, Sweden and United Kingdom. Sonali N. Shah's co-authors include Gregory A. Nichols, Gergana Zlateva, Thomas McRae, Howard Fillit, Jerrold Hill, Jonathan C. Javitt, Robert Futterman, Nathan L. Kleinman, Wendy D. Lynch and Andrew G. Bushmakin and has published in prestigious journals such as PLoS ONE, Annals of Oncology and Journal of General Internal Medicine.

In The Last Decade

Sonali N. Shah

19 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonali N. Shah United States 12 150 113 71 62 61 19 499
P Fender France 11 99 0.7× 41 0.4× 51 0.7× 39 0.6× 14 0.2× 35 378
Laura Cohen United States 11 79 0.5× 27 0.2× 37 0.5× 34 0.5× 9 0.1× 33 448
Robin Flaig United Kingdom 5 95 0.6× 103 0.9× 35 0.5× 18 0.3× 11 0.2× 12 647
Sonali Shah United States 7 150 1.0× 40 0.4× 107 1.5× 27 0.4× 32 0.5× 14 757
Steffen Böhler Germany 12 288 1.9× 28 0.2× 68 1.0× 55 0.9× 26 0.4× 17 641
Mariana Tatsch Brazil 7 54 0.4× 238 2.1× 89 1.3× 21 0.3× 18 0.3× 14 475
Douglas Gause United States 11 201 1.3× 250 2.2× 23 0.3× 48 0.8× 113 1.9× 20 729
Tamara Harris United States 9 75 0.5× 29 0.3× 39 0.5× 25 0.4× 15 0.2× 13 819
Eric Yin Hao Khoo Singapore 15 206 1.4× 23 0.2× 36 0.5× 25 0.4× 14 0.2× 36 618
Valérie Macioce France 13 55 0.4× 26 0.2× 16 0.2× 13 0.2× 16 0.3× 40 381

Countries citing papers authored by Sonali N. Shah

Since Specialization
Citations

This map shows the geographic impact of Sonali N. Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonali N. Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonali N. Shah more than expected).

Fields of papers citing papers by Sonali N. Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonali N. Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonali N. Shah. The network helps show where Sonali N. Shah may publish in the future.

Co-authorship network of co-authors of Sonali N. Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Sonali N. Shah. A scholar is included among the top collaborators of Sonali N. Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonali N. Shah. Sonali N. Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Morlock, Robert, et al.. (2021). COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders. PLoS ONE. 16(1). e0245586–e0245586. 18 indexed citations
2.
Morgans, Alicia K., Zsolt Hepp, Sonali N. Shah, et al.. (2021). Real-world burden of illness and unmet need in locally advanced or metastatic urothelial carcinoma following discontinuation of PD-1/L1 inhibitor therapy: A Medicare claims database analysis. Urologic Oncology Seminars and Original Investigations. 39(10). 733.e1–733.e10. 9 indexed citations
3.
Hepp, Zsolt, et al.. (2021). Real-World Outcomes in Locally Advanced or Metastatic Urothelial Carcinoma Following Platinum and PD-1/L1 Inhibitor Therapy. Future Oncology. 17(32). 4343–4353. 4 indexed citations
4.
Martin, Susan, et al.. (2021). Qualitative Analysis of Pain in Patients With Locally Advanced or Metastatic Urothelial Carcinoma. Bladder Cancer. 8(1). 45–53. 1 indexed citations
5.
McGregor, Bradley A., Peter H. O’Donnell, Arjun Vasant Balar, et al.. (2019). Quality of life of metastatic urothelial cancer (mUC) patients treated with enfortumab vedotin (EV) following platinum-containing chemotherapy and a checkpoint inhibitor (CPI): Data from EV-201 cohort 1. Annals of Oncology. 30. v367–v368. 3 indexed citations
6.
Margolis, Jay, Nicole Princic, David M. Smith, et al.. (2019). Economic Impact of Adherence to Pain Treatment Guidelines in Chronic Pain Patients. Pain Medicine. 20(10). 1907–1918. 10 indexed citations
7.
Romanelli, Robert J., et al.. (2017). Patient characteristics and healthcare utilization of a chronic pain population within an integrated healthcare system.. PubMed. 23(2). e50–e56. 20 indexed citations
8.
Halpern, Rachel, Sonali N. Shah, Joseph C. Cappelleri, Elizabeth T. Masters, & Andrew Clair. (2015). Evaluating Guideline‐recommended Pain Medication Use Among Patients with Newly Diagnosed Fibromyalgia. Pain Practice. 16(8). 1027–1039. 27 indexed citations
9.
Chen, Shih‐Yin, et al.. (2014). Moving Branded Statins to Lowest Copay Tier Improves Patient Adherence. Journal of Managed Care Pharmacy. 20(1). 34–42. 15 indexed citations
10.
Suehs, Brandon T., José Alvir, Nick C. Patel, et al.. (2013). The Clinical and Economic Burden of Newly Diagnosed Alzheimer’s Disease in a Medicare Advantage Population. American Journal of Alzheimer s Disease & Other Dementias®. 28(4). 384–392. 51 indexed citations
11.
Kleinman, Nathan L., et al.. (2013). Direct and Indirect Costs of Women Diagnosed With Menopause Symptoms. Journal of Occupational and Environmental Medicine. 55(4). 465–470. 54 indexed citations
12.
Javitt, Jonathan C., Gergana Zlateva, Stephanie Earnshaw, et al.. (2008). Cost-Effectiveness Model for Neovascular Age-Related Macular Degeneration: Comparing Early and Late Treatment with Pegaptanib Sodium Based on Visual Acuity. Value in Health. 11(4). 563–574. 22 indexed citations
13.
Zlateva, Gergana, Jonathan C. Javitt, Sonali N. Shah, Zhiyuan Zhou, & Jane G. Murphy. (2007). COMPARISON OF COMORBID CONDITIONS BETWEEN NEOVASCULAR AGE–RELATED MACULAR DEGENERATION PATIENTS AND A CONTROL COHORT IN THE MEDICARE POPULATION. Retina. 27(9). 1292–1299. 34 indexed citations
14.
Nichols, Gregory A., et al.. (2007). Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic Control. Journal of General Internal Medicine. 22(4). 453–458. 116 indexed citations
15.
Zlateva, Gergana, M. Patel, & Sonali N. Shah. (2006). Quality of Life in Patients with Age–related Macular Degeneration: Results from the VISION Study. Investigative Ophthalmology & Visual Science. 47(13). 2152–2152. 3 indexed citations
16.
Javitt, Jonathan C., Stephanie Earnshaw, Christopher N. Graham, et al.. (2006). Cost–Effectiveness of Macugen® versus No Treatment in Age–Related Macular Degeneration Patients. 47(13). 1135–1135. 2 indexed citations
17.
Keohane, Denis, et al.. (2006). Patterns of cholinesterase-inhibitor use in the nursing home setting: A retrospective analysis. ˜The œAmerican journal of geriatric pharmacotherapy. 4(2). 154–160. 27 indexed citations
18.
Hill, Jerrold, et al.. (2005). Patterns of healthcare utilization and costs for vascular dementia in a community-dwelling population. Journal of Alzheimer s Disease. 8(1). 43–50. 50 indexed citations
19.
Wimo, Anders, et al.. (2004). Impact of donepezil treatment for Alzheimer's disease on caregiver time. Current Medical Research and Opinion. 20(8). 1221–1225. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P Fender Breakdown of academic impact, for papers by Laura Cohen Breakdown of academic impact, for papers by Robin Flaig Breakdown of academic impact, for papers by Sonali Shah Breakdown of academic impact, for papers by Steffen Böhler Breakdown of academic impact, for papers by Mariana Tatsch Breakdown of academic impact, for papers by Douglas Gause Breakdown of academic impact, for papers by Tamara Harris Breakdown of academic impact, for papers by Eric Yin Hao Khoo Breakdown of academic impact, for papers by Valérie Macioce
Rankless by CCL
2026